The focus is on the effectiveness of new Alzheimer’s drugs, Lecan and aducanumab Umab, and their impact on patients. Despite patients traveling to New York for these drugs, trials reveal only slight improvements. In contrast, B vitamins and Omega-3 show significant effects on dementia. Anti-amyloid drugs are associated with adverse effects, including deaths. Emphasis is placed on controlling brain health through lifestyle choices and cognitive function tests.
Are Standing Desks Enough to Eliminate the Health Risks of Having a Desk Job?
3.5 min • 5 days ago
